Summary
Samples from the L-428 Hodgkin's cell line and from several other lymphoma cell lines were lysed and the soluble proteins were subjected to one-or two-dimensional gel electrophoresis. The separated proteins were transferred to nitrocellulose by the Western Blot technique; antibody reactivity was detected by an immunoperoxidase reaction. Of 152 sera from patients with Hodgkin's disease (HD) 26 (17%) reacted with protein P-65 whereas in the control group, consisting of 35 healthy persons and 20 patients with other malignant diseases only 1 serum was reactive. Thus, the difference between the two groups was highly significant (P<0.01). These antibodies were most common in stage III HD. Splenectomy had no effect on the incidence of these antibodies, and there seemed to be no correlation with B-symptoms or with the histological subtype.
Similar content being viewed by others
References
Akolkar PN, Advani SH, Gothoskar BP (1983) Circulating immune complexes in Hodgkin's disease. Neoplasma 30 (1):73–79
Amlot PL, Slaney JM, Williams BD (1976) Circulating immune complexes and symptoms in Hodgkin's disease. Lancet I:449–451
Brown CA, Hall CL, Long JC, Carey K, Weitzman SA, Aisenberg AC (1978) Circulating immune complexes in Hodgkin's disease. Am J Med 64:289
Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stein H, Gerdes J, Boie C (1981) Hodgkin's disease: establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol 101:111–124
Dölken G, Löhr GW (1980) Isolation of autologous antibodies to antigens associated with Hodgkin's disease. Biomedicine 33:163–167
Dölken G, Hecht T, Weitzmann U, Wagner M, Löhr GW, Hirsch FW (1986) Purification of a polypeptide complex (p52) belonging to the D-subspecifities of Epstein-Barr virus-induced early antigens. Virology 148:58–73
Dölken G, Hecht T, Röckel D, Hirsch FW (1987) Characterization of the Epstein-Barr virus-induced early polypeptide complex P50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies. Virology 157:460–471
Epstein AL, Achong BG, Barr YM, Zayak B, Henle G, Henle W (1966) Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Caner Inst 37:547–559
Euler HH, Beress R, Moldenhauer J, Löffler H (1983) Precipitable immune complexes in Hodgkin's disease. In J. Cancer 32:437–441
Garzelli C, Taub FE, Scharff JE, Prabhakar BS, Ginsberg-Fellner F, Notkins AL (1984) Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J Virol 52:722–725
Hirsch FW, Nall KN, Busch FN, Morris HP, Busch H (1978) Comparison of abundant cytosol proteins in rat liver, Novikoff hepatoma, and Morris hepatoma by two-dimensional gel electrophoresis. Cancer Res 38:1514–1522
Hirsch FW, Bröckl C, Bross KJ, Dölken G (1983) Characterization of lymphoid cells by two-dimensional mini gel electrophoresis of proteins. J Cancer Res Clin Oncol 105:166–172
Hirsch FW, Wagner M, Bross KJ, Guttkowski K, Dölken G, Löhr GW (1984) Immunoglobulin light chains in chronic lymphocytic leukemia and related diseases. Blut 49:339–345
Kissmeyer-Nielsen F, Kjerbye KE, Lamm LU (1975) HLA in Hodgkin's disease. III. A prospective study. Transplant Rev 22:168–174
Lämmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T-4. Nature 227:680–685
Long JC (1979) The immunopathology of Hodgkin's disease. Clin Hematol 8:531–566
Long JC, Hall CL, Brown CA, Statmos C, Weitzmann SA, Carey K (1977) Binding of soluble immune complexes in sera of patients with Hodgkin's disease to tissue cultures derived from the tumor. N Engl J Med 297:295–299
Menezes J, Leibold W, Klein G, Clements G (1975) Establishment and characterization of an Epstein-Barr virus (EBV) negative lymphoblastoid B-cell line from an exceptional, EBV genome negative African Burkitt's type lymphoma. Biomedicine 22:276–284
Miller G, Lipmann M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190–194
Nielsen JL, Andersen P, Ellegaard J (1982) Influence of residual splenic tissue on autoantibodies in splenectomized patients. Scand J Hematol 28:273–277
Notkins AL, Onodera T, Prabhakar BS (1984) Virus-induced autoimmunity. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis. Springer, Berlin Heidelberg New York, pp 210–215
O'Farrell OP (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007–4021
Pulvertaft RJV (1965) A study of malignant tumors in Nigeria by short-term tissue culture. J Clin Pathol 18:261–273
Schaadt M, Diehl V, Stein H, Fonatsch C, Kirchner HH (1980) Two neoplastic cell lines with unique features derived from Hodgkin's disease. Int J Cancer 26:723–731
Slanina J, Wannenmacher M, Spratler J (1985) Schwangerschaft und Kindesentwicklung nach Therapie des M. Hodgkin. Strahlentherapie 161:558–564
Stein H, Gerdes J, Kirchner H, Diehl V, Schaadt M, Bonk A, Steffen T (1981) Immunohistological analysis of Hodgkin's and Sternberg-Reed cells; detection of a new antigen and evidence for selective IgG uptake in the absence of B-cell, T-cell and histiocytic markers. J Cancer Res Clin Oncol 101:125–134
Storch H, Uhlig S, Ludwig R (1980) Autoantikörper bei malignen Tumoren. Z Ges Inn Med 35:471–474
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. G. W. Löhr on the occasion of this 65th birthday
Supported by the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Hirsch, F.W., Scholl, J. & Dölken, G. Serum antibodies to a normal cellular protein (P-65) in patients with Hodgkin's disease. J Cancer Res Clin Oncol 114, 204–207 (1988). https://doi.org/10.1007/BF00417838
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00417838